Subject index, 2000
A print friendly PDF version (PDF 55 KB) is available.
A | B | C | D | E | F | G | H | I | J-K | L | M | N | O | P | Q | R | S | T | U-V | W | X-Y-Z
Top of page
A
Abattoir workers; 154-156, 158-160, 384
Absenteeism, Australia Post; 10, 55-56, 137, 215, 246-247, 279-280, 312
Aboriginal; 48-50, 90-92, 93-94, 165, 343, 368-372, 384, 386-389
ACIR
See: Australian Childhood Immunisation Register
Acute flaccid paralysis; 8, 119-120, 300-303, 364
Acute febrile illness
USA; 296
Adverse Drug Reactions Committee; 28-29
Adverse Event Following Immunisation (AEFI)
adverse events, definitions; 32-33
AEFI definition; 257-258
report; 257-258
measles; 27-33
Aedes spp; 327, 365-366
AIDS
See: HIV and AIDS
Anaphylaxis; 8, 28-31, 258
Anthrax
overseas brief, Ethiopia; 227
reporting; 373
Antibiotic
animal feed; 297-298
azithromycin; 389
doxycycline; 407
pertussis, and; 376-379
resistance
editorial; 297-298
Expert Advisory Committee on Antibiotics; 298
gonococcal; 1-4, 9, 194, 269-271
pneumococcal; 340-343
virginiamycin; 298
see also: JETACAR
susceptibility; 1-4, 182-188, 193, 194, 256, 273, 341
amoxycillin; 17, 63, 115, 256, 289, 343
ampicillin; 17, 63, 115, 256, 289
cephalosporin; 3, 63, 91, 114-115, 186, 188, 271, 289, 340-342
cefotaxime; 341-342
ceftriaxone; 3, 9, 18, 64, 115, 116, 186, 256, 290
chloramphenicol; 4, 188
ciprofloxacin; 2, 9, 18, 64, 115, 116, 256, 290, 362
erythromycin; 91, 341-342
furazolidone; 362
norfloxacin; 362
penicillin; 2, 9, 17, 90, 91, 115, 185, 193, 256, 269, 270, 289, 290, 340-343
penicillinase-producing Neisseria gonorrhoeae (PPNG); 2, 17, 63, 64, 115, 193, 194, 256, 269, 289, 290
quinolone; 2, 3, 18, 64, 114-116, 188, 256, 269, 270
quinolone-resistant Neisseria gonorrhoeae (QRNG); 2, 18, 116, 256, 270, 290
rifampicin; 186, 188, 341-342
spectinomycin; 3, 9, 18, 64, 114-116, 256, 269, 271, 290
tetracycline; 3, 18, 114-116, 271, 341-342, 362
tetracycline resistant Neisseria gonorrhoeae (TRNG); 9, 17, 18, 64, 115, 116, 271, 290
thiamphenicol; 4
vancomycin; 341-342
Antimalarial; 394, 407
ANZFA
See: Australian and New Zealand Food Authority
Arboviruses
reporting; 373
surveillance report; 127, 170
Arthritis; 31, s69, 333
ASPREN
See: Australian Sentinel Practice Research Network
Australian and New Zealand Food Authority; 95, 385
Australian Childhood Immunisation Register; 8, 52, 161-164, 260
See also: Childhood Immunisation Coverage, reports
Australian encephalitis
See Sentinel Chicken Surveillance Programme
Australian Gonococcal Surveillance Programme; 9, 190-191
See also: Gonococcal, surveillance; National Neisseria Network
Australian Malaria Register; 6
Australian Meningococcal Surveillance Programme; 186, 191-193
See also: Meningococcal, surveillance
Australian Mycobacterium Reference Laboratory Network; 6
Australian National Polio Reference Laboratory; 6
report; 118-121, 300-303
See also: Polio
Australian National Polio Certification Committee; 300
Australian Paediatric Surveillance Unit; 6, 120, 300-302
Australian Sentinel Practice Research Network
surveillance
data in CDI, explanation; 7-8, 146-147, 149
non-notifiable disease reporting; 373
influenza; 136, 146, 215, 246-247, 279-280, 311-312, 379-383
report; 16, 40, s85, 106, 135, 136, 177, 221, 255, 289, 321, 359
Top of page
B
Barmah Forest virus; 170, 363
surveillance report; 393
warning; 363
Bloodborne diseases
surveillance report; 56, s78, 96, 126, 169
Boat people; 25-26, 386-389, 394
Bordetella pertussis
See: Pertussis
Botulism; 12
Bovine spongiform encephalopathy (BSE)
beef imports, suspension; 385
blood donors
Australia; 267
CJD, variant, and; 265-266
editorial; 265-266
overseas briefs
France; 309, 362-363
Germany; 362
Spain; 362
United Kingdom; 295, 309, 326
Top of page
C
Campylobacter spp.; 49-50
surveillance report; 348-349, 391
Case definition; 121, 147, 272, 299, 329-331, 337, 344, 373, 376, 380, 383, 387
CDI
See: Communicable Diseases Intelligence
CDNANZ
See: Communicable Diseases Network Australia New Zealand
Chickenpox
See: Australian Sentinel Practice Research Network
Childhood Immunisation Coverage
letter; 260, 268
pertussis; 375-379
re-evaluation of estimates; 161-164, 260, 268
summary, 1993-1998; 276, 277
surveillance report, quarterly; 42, 109, 225, 324
Chlamydia
azithromycin; 389
screening; 390
surveillance report; s78-s79, 96, 126, 169, 213, 349, 392
Cholera
overseas briefs
Afghanistan; 296
Comoros; 20
Madagascar; 44, 67, s88
Marshall Islands; 406
Pohnpei, Micronesia; 143, 179, 227, 295-296, 363-364
Somalia; 144
South Africa; 326
surveillance report; s78
Ciguatera poisoning, outbreak; 344-346
Classical CJD (cCJD)
See: Creutzfeldt-Jakob disease
CJD
See: Creutzfeldt-Jakob disease
Communicable Diseases Intelligence
editorial
antibiotic resistance; 297
CDI, future; 374
CJD surveillance; 265-266
measles
case definition, surveillance and; 329-331
vaccination; 241-242
national disease reporting; 373-374
letters to the Editor; 260, 268, 299, 331
publication; s72, 374
supplements
March; s69-s88
June; Vaccine Preventable Diseases, 1993-1998
Technical Report Series, No 5; 241-242, 277, 299, 331
surveillance data in CDI, explanation; 6-10, 34, 55, s77, 96, 281
Communicable Diseases Network Australia New Zealand; 6, 373, 374
Communicable diseases surveillance
definition; 6, 373
enhanced; 125, 199, 329-331, 332-335, 336, 373
national reporting; 373-374
immigrants; 21-26
report; 11-17, 17-19, 35-40, 40-42, 55-63, 63-65, s77-s85, s86, 96-106, 107-109, 126-136, 136-140, 168-177, 178, 213-221, 222-225, 243-255, 256-259, 278-289, 289-292, 310-312, 322-324, 348-359, 360-361, 391-404, 404-405
tables; 13-17, 36-40, 57-63, s81-s85, 99-106, 129-136, 171-177, 215-221, 247-255, 280-289, 313-319, 319-321, 351-357, 357-359, 395-401, 401-404
Corynebacterium diphtheriae
See: diphtheria
Coxsackie virus; 301
Creutzfeldt-Jakob disease (CJD, cCJD, vCJD)
blood donation; 266, 267
editorial; 265-266
iatrogenic vCJD; 264, 265-266
overseas briefs
France; 20
Germany; 363
United Kingdom; 20, 295, 326
surveillance; 265-266
variant CJD (vCJD); 265-266
See also: Bovine spongiform encephalopathy
Cruise ship; 45-47, 294-295
Crimea-Congo haemorrhagic fever; 180, 373
Cryptosporidiosis
outbreak; 236-239
reporting; 373
Culex spp.; s74, s75, 369-370
Top of page
D
Dengue
control measures; 365-368
East Timor, persons returning from; 365-368
overseas briefs, Palau, Micronesia; 328, 406
rash; 329, 366
surveillance
advanced; 365-367
report; 12, 35, 56, s79, 96, 127, 170
Diarrhoea
See: gastrointestinal disease
Diphtheria
ASPREN; 8
Australian trends, review; 165-167
New Zealand; 167
Soviet Union; 166
summary 1993-1998; 276
See also: Childhood Immunisation Coverage
Drugs, illicit; 203-205
Dysentery, Sierra Leone, Lesotho; 44
Top of page
E
East Timor; 25, s80, 235, 365-368, 407
Ebola haemorrhagic fever
overseas brief, Uganda; 326, 408
reporting; 373
vaccine; 362
Echovirus
outbreak; 121-124
overseas brief, South East Asia; 327
surveillance report; s72, 98
Editorial
See: Communicable Diseases Intelligence
Encephalitis
case; 291, 368-372
surveillance report; 213, 246, 360
warning; 246
see also: Japanese encephalitis, Murray Valley
Encephalopathy; 8, 28, 30-32
Enteroviruses
identification; 118-120, 208-209, 300-302, 406
isolation; 300-303
overseas briefs
Korea; 295
South East Asia; 327, 406
See also: echovirus, polio, coxsackie
Erythema infectiosum; s69-s71
Escherichia coli
drinking water; 49, 337
overseas briefs
Canada; 180
Spain; 406
shiga-like toxin (verotoxin) producing; 12
surveillance report; 12, 56, s78, 96, 169, 243, 310, 349, 391
Top of page
F
Flavivirus
surveillance report; 40, s86, 138-139, 360
Townsville; 367
Western Australia; 368-370, 372
See also: individual diseases, viruses, Sentinel Chicken Surveillance Programme
Food policy; 95, 385
Foodborne disease; 48
global salmonella surveillance; 228
outbreak; 303, 344-346, 347a, 347b
regulation Review; 95
sentinel surveillance; 95
Staphylococcus aureus, Japan; 227
surveillance report; 57, 243, 349
typhoid; 235
vCJD; 266, 385
See also: gastrointestinal disease; ciguatera poisoning
Food-producing animals, antibiotics and; 298
Top of page
G
Gastrointestinal disease;
adverse event following immunisation; 258
ASPREN; 8
ciguatera poisoning; 344-346
cryptosporidiosis; 236-239
India; 362
immigrants; 24
Norwalk-like virus, outbreak; 229-233
rotavirus; 10, 195
salmonellosis; 305-306, 336-340, 347a, 347b
shigellosis; 246, 272-275
Small Round Structured Virus; 48-50
surveillance report; 12, 35, 56, 96, 126, 169, 213, 243, 310, 348, 391-392
viral; 303
Gonococcal
Advisory Group; 193
annual report 1999 - surveillance; 113-117
antibiotic
resistance; 269-271
susceptibility; 1, 17, 114-117, 190, 193, 194
HIV, and; 269
quarterly report; 17-18, 63-64, 256-257, 289-290
screening; 390
surveillance
data in CDI, explanation; 9
report; 1, 56, s79, 126, 169
Top of page
H
Haemolytic uraemic syndrome
overseas brief; Spain; 406
reporting; 373
surveillance report; 12, 35, s78, 96, 126
Haemophilus ducreyi, chancroid; 269, 373
Haemophilus influenzae B
quarterly review; 239
summary 1993-1998; 276
surveillance
report; 97, 126, 214, 392
scheme; 94
See also: Childhood Immunisation Coverage
Haemorrhagic fever; s67, s88, 111, 366, 408
overseas briefs
Afghanistan; 180, 227, 263
Congo; s67, s88, 111
see also: dengue
Hand, foot and mouth disease
Singapore; 295, 327
South East Asia; 327, 406
Hantavirus
overseas brief; s67
Health
drinking water; 338-339
eating habits; 345
environmental; 200-201
facilities, measles in; 211-212
hospital-acquired infection; 298
infection control; 157, 298
legislation; 373
nursing home, gastroenteritis; 229-233, 272-274
policy; 26
Public Health Laboratory; 90, 91
Public Health Unit (PHU)
Alice Springs; 48
Brisbane North; 230
Brisbane South Side; 230, 236, 272-274
Central, Rockhampton; 336
Gasgoyne; 375, 377
Kimberley; 386-387, 389-390
Northern Rivers; 158
South Coast; 272-274
South East Sydney; 203, 233, 236, 305
South Western Sydney; 121, 124
Tropical; 211-212, 332, 366-367
surveillance, role in; 332-335, 373
West Moreton; 231
Western Australia; 372
refugees; 21-26
swimming pool, codes of practice; 238
Hepatitis A
outbreak report; 203-205
surveillance report; 12, 35
Hepatitis B
surveillance report; 243
vaccine, adverse event; 257
Hepatitis C
nosocomial transmission, Germany; 407-408
publication, new; 275
surveillance
enhanced; 373
report; 56, s78, 96, 126, 169
Herpes virus-6; 329
Hib Case Surveillance Scheme; 6
HIV and AIDS
gonococcus, and; 269
publication, new; 275
surveillance
data in CDI, explanation; 7
report; 18, 19, 41, 64, 108, 139-140, 178, 224, 259, 292, 323, 360, 404-405
Hydrops fetalis; s69-s71
Top of page
I
Immigrants 20-26, 299, 366-367, 386, 388-389, 394
Immunisation
coverage; 161-164, 260, 268, 276-277
measles
control; 54
vaccine, possible adverse effects; 51
See also: Adverse Event Following Immunisation; Australian Childhood Immunisation Register; Childhood Immunisation Coverage
Indigenous; 90, 93, 94
See also: Aboriginal
Infantile diarrhoea; 373
Infection control; 157
Influenza
ASPREN; 7, 379-383
avian; 327
case definition; 380, 383
influenza A outbreak
Fair Princess cruise; 294-295
trans Tasman cruise; 45-47
National Influenza Surveillance Scheme, Annual Report, 1999; 9, 145-152
overseas brief
Canada; 327
Hong Kong; 327
USA; 227
surveillance
data in CDI, explanation; 7, 9, 10
report; 136, 137, 160, 214-215, 246-247, 257-258, 279-280, 311-312
Tropical Influenza Surveillance; 9
vaccination, NHMRC recommendations; 152
vaccine composition
for 2000 season; 152
for 2001 season; 306, 384
Top of page
J
Japanese encephalitis
reporting; 373
surveillance; 373
vector; s75
See also: encephalitis
JETACAR
See: Joint Expert Technical Advisory Committee on Antibiotic Resistance
Joint Expert Technical Advisory Committee on Antibiotic Resistance
editorial; 297-298
K
Kosovo; 21, 24, 111
Kunjin virus
reporting; 8, 373
surveillance report; 18, s86, 138, 139, 223, 290
Western Australia; 368-372
Top of page
L
LabVISE
See: Virology and Serology Laboratory Reporting Scheme
Lassa fever
overseas briefs
Daru, Sierra Leone; 227
Germany; 20, 44
Netherlands; 228, 262
United Kingdom; s88
reporting; 373
Legionella spp; s72, 127, 170, 199, 311
Legionellosis
editorial comment; s73
Fair Princess cruise; 294-295
outbreak report; s72, 92, 199-202
overseas brief, Paris, 407
surveillance report; 57, s80, 98, 127, 128, 170, 214, 279, 311, 350, 392-393
testing; s73
Legionnaire's disease
See: legionellosis
Leptospira spp.
See: leptospirosis
Leptospirosis
national surveillance; 153-157
outbreak report; 158-160, 384
Letters to the Editor
See: Communicable Diseases Intelligence
Lice; 25
Listeria monocytogenes
See: Listeriosis
Listeriosis
overseas briefs
Canada; 296
France; 67, 296
USA; 296, 407
surveillance report; 56, 214
Lower respiratory tract infection (LRTI)
See: respiratory tract infection
Lyssavirus; 373
Top of page
M
Malaria
Africa; 407
Boat people; 394
East Timor, persons returning from; 367
surveillance report; s79, 80, 97, 127, 170, 279, 394
See also: antimalarials
Marburg haemorrhagic fever
overseas briefs, Congo; 67, s88, 111
reporting; 373
Measles
adverse event following immunisation; 27-33
case definition; 329-331
control campaign updates; 27, 54
editorial; 241-242, 329-331
Elimination Advisory Committee; 27, 241
guidelines for control; 241, 299, 331
letter; 299, 331
outbreak report; 142-143, 211-212
quarterly report; 240
publication, new; 277
overseas brief; Ireland; 263
summary 1993-1998; 276
surveillance
enhanced; 329-331, 373
report; 11, 55, 97, 127, 168, 214, 245, 278, 310, 311, 349, 392
See also: Childhood Immunisation Coverage
Meningitis
adverse event following immunisation; 258
echovirus; 121-124
overseas brief, Angola; 408
pneumococcal; 342
viral; s72
See also: echovirus; meningococcal disease
Meningococcal disease
antibiotic
susceptibility; 185-186, 191-192
use, in; 333-335
Annual Report 1999, surveillance; 181-188
pilgrims; 111-112
outbreak report; 332-335
overseas briefs
Central African Republic; 67
Ethiopia; s88, 111, 263
France; 111, 144
Hungary; 20
international; 144
Netherlands; 112, 144
Oman; 111, 144
Rwanda; 263
Saudi Arabia;112, 114
Sudan; 111
United Kingdom; 111, 144
USA; 112, 144
surveillance
enhanced; 332-335, 373
report; 55, s72, s78, 98, 127, 170, 214, 246, 279, 311, 350, 393
Mosquito
breeding; 363, 366-372, 394
containment; 327, 365-367, 372
exotic; s74, s75
Mumps
adverse events; 27-33
control campaign updates; 54
quarterly report; 241
summary 1993-1998; 276
surveillance report; 97, 127, 168, 244, 278, 310
See also: Childhood Immunisation Coverage
Murray Valley encephalitis
encephalitis; 291, 368-372
rash; 369-370
virus activity,
see: Sentinel Chicken Surveillance Programme
reporting; 8, 373
southerly spread; 368-372
surveillance report; 18, s86, 127, 138, 139, 170, 222-223, 291
Top of page
N
National Centre for Disease Control
food policy; 95
workshop; 125
National Centre for Immunisation Research and Surveillance
pneumococcal disease Workshop; 89
publication, new; 210
report; 241
role; 125, 167, 241
vaccination update workshop; 51
National Centre in HIV Epidemiology and Clinical Research; 7, 125
National Childhood Immunisation Program; 8, 28
National Enteric Pathogens Surveillance Scheme; 304
National Health and Medical Research Council; 6, 8, 27, 297-298, 337, 339, 373
National Influenza Surveillance
See: Influenza
National Mycobacterial Surveillance System; 6
National Neisseria Network; 6, 182, 186-188, 190-193
National Notifiable Diseases Surveillance System; 6
editorial; 373
expanded surveillance; 125, 373
diseases, revised list of notifiable; 242
surveillance data in CDI, explanation; 6-10, 34, 55, s77, 96
See also: Communicable Diseases Surveillance, report
National Plan for Poliovirus Containment; 207-210
National Polio Reference Laboratory; 300-303
National Rotavirus Reference Centre; 10, 107, 195
Neisseria gonorrhoeae
See: Gonococcal
Neisseria meningitidis
See: Meningococcal
New variant Creutzfeldt-Jakob disease
See: Creutzfeldt-Jakob disease
NCIRS
See: National Centre for Immunisation Research and Surveillance
NNDSS
See: National Notifiable Diseases Surveillance System
Norwalk-like virus; 48-49
outbreak report; 229-232
surveillance report; 391
Notifiable diseases
See: National Notifiable Diseases Surveillance System
Top of page
O
Operation Save Haven; 21-26
Ornithosis
outbreak report; 350
surveillance report; 12
Otitis media; 90
Overseas briefs; 20, 44, s67, s88, 111, 112, 144, 227-228, 262-264, 294-296, 326-328, 362-364, 406-408
Overseas travel; 46-47, 54, s76, 111, 234-235, 243-245, 364, 382-383
Top of page
P
Parainfluenza virus, surveillance report; 128
Paratyphoid fever; 233-236
Parotitis; 31
Parvovirus
B19, in pregnancy; s69-s71
rash; 329
Pertussis
antibiotic use; 91, 378
case definition; 376
outbreak; 375-379
quarterly report; 240
summary 1993-1998; 276
surveillance report; 11, 35, 55, s77, 97-98, 126-127, 168, 245, 278, 310-311, 349, 392
See also: Childhood Immunisation Coverage
PHLN
See: Public Health Laboratory Network
Pilgrim; 54, s76, 111-112
Plasmodium spp.
surveillance report; s80, 97, 127, 170, 394
See also: malaria
Pneumococcal disease
antibiotic susceptibility; 90-92, 93-95, 340-343
surveillance; 93-95
enhanced; 373
workshop report; 89-92
Pneumonia; 151-152
pneumococcal; 90, 340-343
Polio
eradication; s76, 118-120, 207-210, 300-303, 304
global; 304
outbreak
China; 44
Dominican Republic and Haiti; 364
summary 1993-1998; 276
vaccine
adverse event following immunisation; 258
India; s76
quarterly report; 240
virus
characterisation; 300-303
Sabin; 301-302, 364
wild, containment; 207-210, 300-303, 304
See also: acute flaccid paralysis; Australian National Polio Reference Laboratory; Childhood Immunisation Coverage
Pregnancy; 24, s69-s71, 299, 387, 389
Psittacosis; 350
See also: ornithosis
Public Health Laboratory
See: Health
Public Health Laboratory Network; 125, 307, 373
Public Health Unit
See: Health
Puerperal fever; 373
Top of page
Q
Quarantinable disease
surveillance report; 56, s78, 96, 126, 169
Quarantine Act; 373
Top of page
R
Rash; 22, 31, s69, 329, 366, 370
Refugees 21
See also: boat people, immigrants
Respiratory syncytial virus (RSV); 376, 381
Respiratory tract infection; 7, 24, 45-47, 341-342, 375-379, 380-383
Rift Valley fever
overseas brief, Saudi Arabia; 295
Ross River virus; 363
surveillance report; 11-12, 35, 37, s79, 96-97, 127, 170, 393-394
warning; 363, 393-394
Rotavirus
National Rotavirus Reference Centre report 1999/2000; 195-198
quarterly report; 322
surveillance data in CDI, explanation; 10, 195
surveillance report, biannual; 107
Rubella
adverse events following immunisation; 27-33
control campaign update; 54
letter; 299
quarterly report; 240
rash; 329
summary 1993-1998; 276
surveillance report; 11, 55, s77, 97-98, 127
See also: Childhood Immunisation Coverage
Top of page
S
Salmonella spp
See: Salmonellosis, typhoid
Salmonellosis
drinking water; 336-340
global surveillance; 228
outbreak report; 305-306, 336-340, 347a, 347b
overseas briefs
India 362
New Zealand, birds; 294
surveillance report; 56, s78, 96, 126, 169, 213, 243, 348, 391
see also: typhoid
Scabies; 25
Scarlet fever; 373
Sentinel Chicken Surveillance Programme
surveillance
data in CDI, explanation; 8-9
report; 18, 40, s86, 138-139, 222-223, 291, 360
Western Australia; 369-372
Serious Adverse Events following Vaccination Surveillance Scheme; 8
See also: Adverse Events Following Immunisation
Shiga-like toxin
See: Escherichia coli
Sexually transmissible diseases
publication, new; 275
surveillance in Australia; 7
surveillance reports; 56, s78, 96, 126, 169
see also: chlamydia, gonococcal, syphilis
Shigella spp
See: shigellosis
Shigellosis
outbreak report; 247, 272-275
surveillance report; 257-258
SLTEC
See: Escherichia coli
Small Round Structured Virus; 48-50, 229
Smallpox; 179, 373
Staphylococcus aureus
food poisoning, Japan; 227
methicillin-resistant; 297
Streptococcus pneumoniae
See: pneumococcal disease
Surveillance
data in CDI, explanation; 6-10, 34, 55, s77, 96, 281
definition; 6, 373
enhanced; 125, 373
See also: Communicable Diseases Surveillance
Syphilis
azithromycin; 389
case definition; 387
screening; 386-390
surveillance report; s79, 126, 169
Top of page
T
Tetanus
ASPREN; 8
quarterly report; 241
summary 1993-1998; 276
surveillance report; 55, 97
See also: Childhood Immunisation Coverage
Tuberculosis; 22, 125
enhanced surveillance; 373
evacuees, Kosovo; 22
World Tuberculosis Day; s72
Tularemia, Kosovo; 111
Typhoid
overseas brief, Samoa; 264
surveillance report; 56, s78, 96, 126, 169, 243, 278, 349, 391
Sydney, south eastern, 1992-1997; 233-236
Typhus; 394
Top of page
U
Upper respiratory tract infection (LRTI)
See: Respiratory tract infection
V
Vaccinia; 179
Vaccination
adult diphtheria/tetanus (ADT); 8, 167
adverse events; 51
definitions; 32-33
measles; 27-33
report; 257-258
incentives; 51-53
influenza; 379-383
measles; 27-33, 241-242, 329
meningococcal; 335
MMR, adverse events; 27-33, 256-257
pertussis; 245, 375-379
pneumococcal; 89-95
providers; 52
recommendations; 27, 47, 94, 152, 167, 241-242
summary 1993-1998; 276-277
yellow fever; 54, s76, 263
young adults;
See: vaccination, measles
See also: Adverse Event Following Immunisation, Childhood Immunisation Coverage; Immunisation
Vaccine
adult diphtheria/tetanus (ADT); 165
ebola virus; 362
hepatitis A; 205
influenza; 152, 306, 384
measles/mumps/rubella; 27-33, 241
pertussis; 375
pneumococcal; 89-95, 343
poliovirus; 207-210, 300-303, 304, 364
rotavirus; 195, 197
Vaccine preventable diseases
measles outbreak; 211-212
publication review; 276-277
summary; 210
quarterly report; 239-241
surveillance report; 11, 35, 55, s77-s78, 97-98, 126-127, 168, 214, 244, 278, 310, 349-350, 392
See also: Childhood Immunisation Coverage
Variant CJD (vCJD)
See: Creutzfeldt-Jakob disease
Varicella
See: chickenpox
Variola; 179
Vector; 57, s74-s75
Vectorborne diseases, surveillance report; 11-12, 35, 56, s79-s80, 96-97, 127, 170, 393
Verotoxin
See: Escherichia coli
Vibrio cholerae
See: cholera
Victorian Infectious Diseases Reference Laboratory; 207-210, 380-383
Virginiamycin; 298
Virology and Serology Laboratory Reporting Scheme, 373
influenza surveillance; 146-149
report
See: Communicable Diseases Surveillance, report
surveillance data in CDI, explanation; 10
VTEC
See: Escherichia coli
Top of page
W
Waterborne disease; 48-49, 336-340
West Nile fever
overseas briefs
Israel; 296
USA; 326, 408
transmission; 326
Whooping cough
See: pertussis
World Health Organization (WHO)
containment of antimicrobial resistance; 297
diagnostic kit, influenza; 408
global salmonella survey; 228
gonococcal antimicrobial surveillance; 6, 269-271
influenza reference centre; 10, 147, 150-151
leptospirosis reference centre; 153
poliomyelitis eradication; 44, s76, 118-120, 207, 209, 300-303, 304
Western Pacific Region; 1-4, 6, s76, 118-120, 207, 209, 269, 300, 302
Top of page
X
X-ray; 22
Y - Z
Yaws; 389
Yellow fever
overseas briefs
Brazil; 44, 54
Guinea; 327
Liberia; 263, 296
Netherlands; 67
Nigeria; 144
vaccination; 54, s76, 263
